Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3275
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05107674 | A Study of NX-1607 in Adults With Advanced Malignancies | ||
| NCT03148691 | A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis | ||
| NCT01690520 | Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes | ||
| NCT03516591 | A Phase 1 Study of AMV564 in Patients With Intermediate or High-Risk Myelodysplastic Syndromes | ||
| NCT03301597 | NLA101 in Adults Receiving High Dose Chemotherapy for AML | ||
| NCT05876780 | A Gene Transfer Single Dose Study to Evaluate the Safety, Tolerability and Efficacy of SRP-9003 in Non-Ambulatory and Ambulatory Participants With Limb Girdle Muscular Dystrophy, Type 2E/R4 (Beta-Sarcoglycan [β-SG] Deficiency) | ||
| NCT03793088 | A Patient-Centric Platform Trial for Precision Oncology | ||
| NCT04919473 | Dose-Escalation Study to Evaluate the Safety and Tolerability of Intravitreal vMCO-I in Patients With Advanced Retinitis Pigmentosa | ||
| NCT06742268 | Extension Study on Safety and Rebound Effect of SAT-001 for Myopia in Children | ||
| NCT03311373 | A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010 | ||
| NCT06058156 | Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis | ||
| NCT05971329 | Pilot Study of ZetaFuse™ Bone Graft for the Treatment of Cervical Degenerative Disc Disease | ||
| NCT04511130 | Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant | ||
| NCT03896009 | Maximizing Outcomes in Treating Acute Migraine | ||
| NCT05276063 | A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) | ||
| NCT02169804 | An Open-Label Study to Evaluate the Effect of Age Upon the Pharmacokinetics of Androxal | ||
| NCT05472649 | Long-Term Follow-Up of Patients Who Received Gene-Modified Cell Therapy | ||
| NCT05643872 | A Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel in the Treatment of Adults With Pachyonychia Congenita | ||
| NCT01452828 | A Pharmacokinetics and Safety Study in Subjects With Renal Impairment | ||
| NCT03265119 | PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations | ||
| NCT03949530 | A Study of Safety & Blood Levels of IDL-2965 in Healthy Subjects and Patients With a Special Type of Pulmonary Fibrosis | ||
| NCT06424444 | A Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease | ||
| NCT06788639 | A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting | ||
| NCT06063330 | Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects | ||
| NCT00699712 | Study to Assess Hemodynamic Effects, Safety and Tolerability of Chimeric Natriuretic Peptide (CD-NP) in Patients With Stabilized Acute Heart Failure (AHF) | ||
| NCT01784536 | Open Label Study Evaluating the Effects of a Single Oritavancin Infusion on Cytochrome P450 in Healthy Volunteers | ||
| NCT04640298 | Study of Cingal® for Symptomatic Relief of Osteoarthritis of Hip Joint | ||
| NCT07260877 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus | ||
| NCT06568367 | Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN) | ||
| NCT04330664 | Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2) | ||
| NCT03216499 | HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma | ||
| NCT02574663 | TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors | ||
| NCT05820100 | Observational Study to Assess the Reliability and Validity of the MLYMT and MLSDT | ||
| NCT04536688 | A Study of RGLS4326 in Patients With Autosomal Dominant Polycystic Kidney Disease | ||
| NCT05831202 | SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial | ||
| NCT02658175 | The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Chylomicronemia Syndrome | ||
| NCT03792971 | Study to Evaluate the Effects of 90 mg Intravenous Infusions of GC4419 on the Single Dose Pharmacokinetics of Dextromethorphan in Healthy Adult Subjects | ||
| NCT05429073 | A Study of RGLS8429 in Healthy Volunteers | ||
| NCT06062069 | A Study of CT-868 in Type 1 Diabetes Mellitus | ||
| NCT02777931 | Efficacy and Safety of NFC-1 in Adolescents With Genetic Disorders Impacting mGluR and ADHD | ||
| NCT05968430 | Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension | ||
| NCT02219711 | Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer | ||
| NCT05227742 | Exploratory Study of Low Dose Psilocybin | ||
| NCT04323475 | Phage Therapy for the Prevention and Treatment of Wound Infections in Burned Patients | ||
| NCT04412057 | Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury | ||
| NCT04159610 | Assessment of Safety, Tolerability and Efficacy of 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% Under Maximum-Use Conditions in Subjects with Primary Axillary Hyperhidrosis | ||
| NCT05558982 | BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma | ||
| NCT03070782 | Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease | ||
| NCT05599802 | Clinical Study of SARS-CoV-2 Variant mRNA Vaccine in Healthy Participants | ||
| NCT05663853 | An Observational Biomarker Study in Multiple Sclerosis (MS) Patients |
